| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $3.04B | +10.2% |
| Gross profit | $1.03B | — |
| Operating income | $0.46B | — |
| Net income | $0.32B | +13.5% |
| Gross margin | 33.7% | Net margin 10.5% |
| Revenue Q/Q | +5.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| Diagnostic Information Services Business | $2.98B | 97.9% |
| All Other Segments | $0.07B | 2.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.02B | 66.3% |
| SG&A | $0.53B | 17.4% |
| Tax & other | $0.14B | 4.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
Q ・ RL ・ RJF ・ RTX ・ O ・ REG ・ REGN ・ RF ・ RSG ・ RMD ・ RVTY ・ HOOD
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies